Evidence map›Paper›PMID 27345730›Full record

ArticleScientific reports2016

Neuroprotection mediated by inhibition of calpain during acute viral encephalitis.

Charles L Howe, Reghann G LaFrance-Corey, Kanish Mirchia, Brian M Sauer, Renee M McGovern, Joel M Reid, Eric J Buenz

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Calpain-2 protein influencesFrontiers in microbiology · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Chemokine receptors CCR2 and CX3CR1 regulate viral encephalitis-induced hippocampal damage but not seizures.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Charles L HoweDepartments of Neurology, Mayo Clinic, Rochester, Minnesota, 55905 USA.
Reghann G LaFrance-CoreyDepartments of Neurology, Mayo Clinic, Rochester, Minnesota, 55905 USA.
Kanish MirchiaDepartments of Neurology, Mayo Clinic, Rochester, Minnesota, 55905 USA.
Brian M SauerNeurobiology of Disease PhD program, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, 55905 USA.
Renee M McGovernDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, 55905 USA.
Joel M ReidDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, 55905 USA.
Eric J BuenzDepartments of Neurology, Mayo Clinic, Rochester, Minnesota, 55905 USA.
Mayo Clinic · US

Funding

Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
Mechanisms of neuronal injury during virus infection of the CNSR01NS064571 · NINDS · MAYO CLINIC ROCHESTER · PI HOWE, CHARLES LEE · 2009 to 2018
$3.0M
New tools to study leukocyte infiltration into the CNSR03NS075395 · NINDS · MAYO CLINIC ROCHESTER · PI HOWE, CHARLES LEE · 2012 to 2013
$156k
NIGMS NIH HHS T32 GM065841NINDS NIH HHS R01 NS064571NINDS NIH HHS R03 NS075395
6 · The paper itself

Abstract

Neurologic complications associated with viral encephalitis, including seizures and cognitive impairment, are a global health issue, especially in children. We previously showed that hippocampal injury during acute picornavirus infection in mice is associated with calpain activation and is the result of neuronal death triggered by brain-infiltrating inflammatory monocytes. We therefore hypothesized that treatment with a calpain inhibitor would protect neurons from immune-mediated bystander injury. C57BL/6J mice infected with the Daniel's strain of Theiler's murine encephalomyelitis virus were treated with the FDA-approved drug ritonavir using a dosing regimen that resulted in plasma concentrations within the therapeutic range for calpain inhibition. Ritonavir treatment significantly reduced calpain activity in the hippocampus, protected hippocampal neurons from death, preserved cognitive performance, and suppressed seizure escalation, even when therapy was initiated 36 hours after disease onset. Calpain inhibition by ritonavir may be a powerful tool for preserving neurons and cognitive function and preventing neural circuit dysregulation in humans with neuroinflammatory disorders.

Indexed as

Acute DiseaseAnimalsCalpainCardiovirus InfectionsCysteine Proteinase InhibitorsHippocampusMiceNeuroprotective AgentsRitonavirTheilovirusCalpainCysteine Proteinase InhibitorsNeuroprotective AgentsRitonavir

Identifiers

PMID27345730
PMCPMC4921808
OpenAlexW2474303587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.